Undetected carrier state in chronic granulomatous disease.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002353:Carrier State; D002648:Child; D002675:Child, Preschool; D005260:Female; D005455:Fluorescent Antibody Technique; D005954:Glucosephosphate Dehydrogenase / Q000097:blood; D005978:Glutathione / Q000097:blood; D005980:Glutathione Reductase / Q000097:blood; D006801:Humans; D005779:Immunodiffusion; D007136:Immunoglobulins; D007962:Leukocytes / Q000201:enzymology; D008297:Male; D009243:NAD / Q000097:blood; D009249:NADP / Q000097:blood; D010088:Oxidoreductases / Q000097:blood; D010544:Peroxidases / Q000097:blood; D010585:Phagocyte Bactericidal Dysfunction / Q000201:enzymology; D010734:Phosphogluconate Dehydrogenase / Q000097:blood; D012706:Serratia marcescens; D013210:Staphylococcus; D013291:Streptococcus; D013778:Tetrazolium Salts
D000900:Anti-Bacterial Agents; D007136:Immunoglobulins; D013778:Tetrazolium Salts; D009243:NAD; D009249:NADP; D010088:Oxidoreductases; D010734:Phosphogluconate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D010544:Peroxidases; D005980:Glutathione Reductase; D005978:Glutathione